VEGF aptamer/i-motif-grafted multi-functional SPION nanocarrier for chemotherapeutic/phototherapeutic synergistic research
Source abstract
Abstract
Chemotherapeutic agents and photosensitizers often suffer from poor tumor selectivity, high side toxicity, or low water solubility. To address these problems, various drug delivery systems (DDS) have been explored but most of them are toxic, difficult to synthesize, or of single function. In order to design a highly biocompatible, conveniently prepared, multi-functional drug delivery system, herein, an aptamer of vascular endothelial growth factor (VEGF) and a cytosine (C)-DNA fragment were grafted on the surface of superparamagnetic iron oxide nanoparticles (SPION), and then a chemotherapeutic agent daunomycin (DNM) and a photosensitizer 5, 10, 15, 20-tetra (phenyl-4-N-methyl-4-pyridyl) porphyrin (TMPyP) were self-assembled with the hybridized VEGF-based DNA structure. By loading DNM and TMPyP, the DDS displayed strong chemotherapeutic/phototherapeutic capability against cancer cells via mechanisms such as mitochondrial dysfunction and ROS elevation, which triggered the apoptosis of the tumor cells. The dual delivery of chemotherapeutical agents and photosensitizers with aptamer/C-rich DNA successfully integrated the functions of pH stimuli-responsive drug release and chemotherapeutic/phototherapeutic modalities into one single system and thus could be considered as an ideal drug delivery vehicle with great potential in clinic.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Health Industry, Zhongshan Torch Polytechnic, Guangdong, China
Cang Zhou People’s Hospital, Cangzhou, China
School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangdong, PR China
Funding
Science and technology innovation strategy of Guangdong Province · Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province · Natural Science Foundation of Guangdong
References (32)
Show source-provided references
1. 10.1016/j.electacta.2021.13799410.1016/j.electacta.2021.137994 ↗
2. 10.1016/j.ijbiomac.2019.11.11810.1016/j.ijbiomac.2019.11.118 ↗
3. 10.1016/j.tibtech.2021.02.00210.1016/j.tibtech.2021.02.002 ↗
4. 10.1016/j.matt.2020.11.00210.1016/j.matt.2020.11.002 ↗
5. 10.1016/j.jhazmat.2020.12341810.1016/j.jhazmat.2020.123418 ↗
6. 10.1016/j.chempr.2020.06.01210.1016/j.chempr.2020.06.012 ↗
7. 10.1016/j.trac.2019.03.00710.1016/j.trac.2019.03.007 ↗
8. 10.1016/j.dyepig.2016.01.00910.1016/j.dyepig.2016.01.009 ↗
9. 10.1016/j.jphotobiol.2017.06.03610.1016/j.jphotobiol.2017.06.036 ↗
10. 10.1016/j.clinbiochem.2021.03.01410.1016/j.clinbiochem.2021.03.014 ↗
11. 10.1016/j.talanta.2017.04.05710.1016/j.talanta.2017.04.057 ↗
12. 10.1016/j.jlumin.2019.02.01910.1016/j.jlumin.2019.02.019 ↗
13. 10.1007/s10856-019-6278-y10.1007/s10856-019-6278-y ↗
14. 10.1016/j.saa.2020.11918510.1016/j.saa.2020.119185 ↗
15. 10.1016/j.bbagen.2020.12965110.1016/j.bbagen.2020.129651 ↗
16. 10.1016/j.reprotox.2021.04.00310.1016/j.reprotox.2021.04.003 ↗
17. 10.1016/j.saa.2014.08.12310.1016/j.saa.2014.08.123 ↗
18. 10.1016/j.bioorg.2015.05.00110.1016/j.bioorg.2015.05.001 ↗
19. 10.1039/C6RA19697G10.1039/C6RA19697G ↗
20. 10.1177/088532821665442510.1177/0885328216654425 ↗
21. 10.1177/088532821988215210.1177/0885328219882152 ↗
22. 10.1016/j.ccr.2020.21341010.1016/j.ccr.2020.213410 ↗
23. 10.1016/j.jcis.2020.11.07610.1016/j.jcis.2020.11.076 ↗
24. 10.1007/978-3-319-66095-0_1110.1007/978-3-319-66095-0_11 ↗
25. 10.15171/apb.2019.02410.15171/apb.2019.024 ↗
26. 10.3390/cancers1307154310.3390/cancers13071543 ↗
27. Varda S · Curr Med Chem · 2017 · 24 · 4435
28. 10.15698/cst2020.06.22110.15698/cst2020.06.221 ↗
29. 10.1016/j.trecan.2017.10.00610.1016/j.trecan.2017.10.006 ↗
30. 10.1016/j.semcdb.2017.05.02310.1016/j.semcdb.2017.05.023 ↗
31. 10.1016/j.molmed.2017.03.00410.1016/j.molmed.2017.03.004 ↗
32. 10.1142/S108842461950154210.1142/S1088424619501542 ↗